Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 9451 AL 9465

Malondialdehyde in cognitive impairment: A systematic review and meta-analysis

Zoroddu S, Sedda S, Mangoni AA, Carru C, Zinellu A.

Neurosci Biobehav Rev. 2026 Feb;181:106531. doi: 10.1016/j.neubiorev.2025.106531. Epub 2025 Dec 20.

A systematic review and meta-analysis of pteridines in mild cognitive impairment and Alzheimer's disease

Mangoni AA, Zinellu A.

BMC Geriatr. 2025 Feb 13;25(1):94. doi: 10.1186/s12877-025-05760-9.

Precision diagnosis of cognitive impairment due to Alzheimer's disease for therapeutic interventions

Knopman DS.

Alzheimers Dement. 2025 Jan;21(1):e14043. doi: 10.1002/alz.14043. Epub 2024 Dec 24.

Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE ε4

Jung JH, Kong N, Lee S; A4 and LEARN Study Teams.

J Prev Alzheimers Dis. 2025 Dec;12(10):100363. doi: 10.1016/j.tjpad.2025.100363. Epub 2025 Sep 3.

Sex differences in the association of Alzheimer's disease biomarkers and cognition in a multicenter memory clinic study

Boccalini C, Peretti DE, Scheffler M, Mu L, Griffa A, Testart N, Allali G, Prior JO, Ashton NJ, Zetterberg H, Blennow K, Frisoni GB, Garibotto V.

Alzheimers Res Ther. 2025 Feb 18;17(1):46. doi: 10.1186/s13195-025-01684-z.

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference

Falgàs N, Maure-Blesa L, Ances B, Flores-Aguilar L, Hartley S, Hassenstab J, Iulita MF, Janicki M, Koenig K, Lao P, Levin J, McDade E, Meijer L, Rafii MS, Snyder HM, Sánchez-Valle R, Fortea J; DSAD‐ADAD conference group; Arriola Infante J, Balasa M, Barroeta I, Barthelemy R N, Bejanin A, Benejam B, Bosch B, Bradshaw A, Carmona-Iragui M, Cohen A, Comas Albertí A, Csincsik L, Cuello AC, Del Hoyo Soriano L, Dijkstra J, Edwards N, Giménez S, Gonzalez-Ortiz F, Gordon B, Gutiérrez Fernández S, Handen B, Jacob C, Johnson E, Johansson C, Lladó A, Lleó A, Morabito S, Morcillo-Nieto AO, Montoliu-Gaya L, Okafor M, Pérez-Millan A, Potier MC, Ringman J, Rodríguez-Baz Í, Rubenstein E, Ryan NS, Strydom A, Vaqué-Alcázar L, Vermunt L, Videla Toro L, Zaman S.

Alzheimers Dement. 2025 Jul;21(7):e70309. doi: 10.1002/alz.70309.

SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies

Kuhn E, Klinger HM, Amariglio RE, Wagner M, Jessen F, Düzel E, Heneka MT, Chételat G, Rentz DM, Sperling RA, Ebenau JL, Butterbrod E, Van Der Flier WM, Sikkes SAM, Teunnissen CE, Van Harten AC, Van De Giessen EM, Rami L, Tort A, Sánchez Benavides G, Gifford KA, Van Hulle C, Buckley RF; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing, A4 Study Team; DELCODE Study; Harvard Aging Brain Study.

Alzheimers Dement. 2025 May;21(5):e14307. doi: 10.1002/alz.14307. Epub 2025 Feb 22.

Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics

Dumurgier J, Défontaines B, Gallouj K, Garcin B, Garnier-Crussard A, Lagarde J, Pauly JM, Rollin Sillaire A, Rouch-Leroyer I, Sarazin M, Verny M, Wallon D.

Rev Neurol (Paris). 2025 Dec;181(10):1021-1029. doi: 10.1016/j.neurol.2025.09.004. Epub 2025 Sep 30.

Early detection of Alzheimer's disease using small RNAs. Results from the EPAD cohort

Sikosek T, Heuvelman M, Mika J, Kahraman M, Jehn J, Frank M, Daniel-Moreno A, Ceiler J, Skottke J, Sanchez-Delgado M, Neubert P, Rudolf C, Tikk K, Horos R, Cummings JL, Butchart J, Ritchie C, Manson J, Steinkraus BR; EPAD consortium.

J Prev Alzheimers Dis. 2025 Sep;12(8):100257. doi: 10.1016/j.tjpad.2025.100257. Epub 2025 Jun 28.

Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study

Kemna RE, Kueck PJ, Blankenship A, John CS, Johnson CN, Green ZD, Mayfield H, Yoksh L, Johnson L, Thyfault JP, Mahnken JD, Miller BF, Morris JK.

Alzheimers Dement. 2025 Dec;21(12):e70984. doi: 10.1002/alz.70984.

Predicting cognitive decline in Alzheimer's disease: A real-life proof-of-principle study on multimodal assessment

Motolese F, Norata D, Iaccarino G, Sapio E, Lodico S, Di Giesi ML, Cruciani A, Rossi M, Pilato F, Di Lazzaro V, Capone F.

J Alzheimers Dis. 2025 Nov;108(1):378-386. doi: 10.1177/13872877251376676. Epub 2025 Sep 10.

Systematic review and network meta-analysis of retinal imaging biomarkers in neurodegenerative diseases: Correlation with brain changes

Nikparast F, Ganji Z, Zare H, Akbari-Sharak N.

Photodiagnosis Photodyn Ther. 2025 Aug;54:104632. doi: 10.1016/j.pdpdt.2025.104632. Epub 2025 May 16.

Associations between plasma beta amyloid and cognitive decline: A systematic review and meta-analysis

Cynthia C, Nugraha J, Hamdan M, Dharma R, Limempouw SF.

Narra J. 2025 Aug;5(2):e2268. doi: 10.52225/narra.v5i2.2268. Epub 2025 May 13.

α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment: Performance and Interactions With CSF and Plasma Biomarkers

Esteller-Gauxax D, Pérez Millan A, Sarto J, Puey R, Guillén Soley N, Tort-Merino A, Falgàs N, Borrego-Écija S, Piñol-Ripoll G, Massons M, Fernandez G, Ruiz García R, Naranjo L, Augé Fradera JM, Antonell A, Sánchez-Valle R, Lladó A, Balasa M.

Neurology. 2025 Oct 7;105(7):e214040. doi: 10.1212/WNL.0000000000214040. Epub 2025 Sep 8.

Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease

Mengel D, Soter E, Ott JM, Wacker M, Leyva A, Peters O, Hellmann-Regen J, Schneider LS, Wang X, Priller J, Spruth E, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Hansen N, Rostamzadeh A, Düzel E, Glanz W, Incesoy EI, Buerger K, Janowitz D, Ewers M, Perneczky R, Rauchmann B, Teipel S, Kilimann I, Laske C, Sodenkamp S, Spottke A, Brustkern J, Brosseron F, Wagner M, Stark M, Kleineidam L, Shao K, Lüsebrink F, Yakupov R, Schmid M, Hetzer S, Dechent P, Scheffler K, Berron D, Jessen F, Synofzik M; DELCODE study group.

Mol Psychiatry. 2025 Jul;30(7):3150-3159. doi: 10.1038/s41380-025-03021-0. Epub 2025 Apr 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias